You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 852 Modified-epitope-based vaccine (OSE2101) combined with anti-PD-1/IL-7v bispecific antibody sustains long-lasting tumor specific antigen memory T cell response in vivo

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
852 Modified-epitope-based vaccine (OSE2101) combined with anti-PD-1/IL-7v bispecific antibody sustains long-lasting tumor specific antigen memory T cell response in vivo

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023126017
Dec 20235809
Jan 20241703
Feb 20242200
Mar 20242400
Apr 202432016
May 20242203
Jun 20242005
Jul 20242805
Aug 20241602
Sep 20242803
Oct 20242207
Nov 202460015
Dec 202452020
Jan 202546011
Feb 20256014
Mar 2025006
Apr 20251011
May 20250010
Jun 2025008
Total5800165